CS249503B2 - Method of new 1-(3-/3,4,5-trimethoxyphenoxy/-2-hydroxypropyl-4-aryl-piperazine derivatives production - Google Patents
Method of new 1-(3-/3,4,5-trimethoxyphenoxy/-2-hydroxypropyl-4-aryl-piperazine derivatives production Download PDFInfo
- Publication number
- CS249503B2 CS249503B2 CS782141A CS214178A CS249503B2 CS 249503 B2 CS249503 B2 CS 249503B2 CS 782141 A CS782141 A CS 782141A CS 214178 A CS214178 A CS 214178A CS 249503 B2 CS249503 B2 CS 249503B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- compound
- acid
- piperazine
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB14100/77A GB1583372A (en) | 1977-04-04 | 1977-04-04 | 1-(3-(3,4,5-trimethoxyphenoxy)-2-hydroxypropyl)-4-aryl piperazine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
CS249503B2 true CS249503B2 (en) | 1987-03-12 |
Family
ID=10034980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS782141A CS249503B2 (en) | 1977-04-04 | 1978-04-03 | Method of new 1-(3-/3,4,5-trimethoxyphenoxy/-2-hydroxypropyl-4-aryl-piperazine derivatives production |
Country Status (23)
Country | Link |
---|---|
JP (1) | JPS6038383B2 (no) |
AR (1) | AR222149A1 (no) |
AT (1) | AT360997B (no) |
AU (1) | AU516315B2 (no) |
BE (1) | BE865642A (no) |
CA (1) | CA1124718A (no) |
CH (1) | CH638795A5 (no) |
CS (1) | CS249503B2 (no) |
DE (1) | DE2814168A1 (no) |
DK (1) | DK145225C (no) |
ES (1) | ES468486A1 (no) |
FI (1) | FI69627C (no) |
FR (1) | FR2395264A1 (no) |
GB (1) | GB1583372A (no) |
HU (1) | HU179952B (no) |
MX (1) | MX6120E (no) |
NL (1) | NL7803540A (no) |
NO (1) | NO149209C (no) |
PL (1) | PL112249B1 (no) |
SE (1) | SE435507B (no) |
SU (1) | SU893133A3 (no) |
YU (1) | YU40513B (no) |
ZA (1) | ZA781889B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4335126A (en) * | 1977-03-10 | 1982-06-15 | Degussa Aktiengesellschaft | 1-[3-(3,4,5-Trimethoxyphenoxy)-2-hydroxy-propyl]-4-aryl-piperazine-derivatives having pharmaceutical activity |
FR2488892A2 (fr) * | 1977-04-04 | 1982-02-26 | Degussa | Nouveaux derives 1-(3-(3,4,5-trimethoxyphenoxy)-2-hydroxypropyl)-4-aryl-piperaziniques, procede pour leur preparation et leur application en tant que medicament |
DE2824764A1 (de) * | 1978-06-06 | 1979-12-20 | Hoechst Ag | Neue pyridylpiperazinderivate und verfahren zu ihrer herstellung |
DE3023369A1 (de) * | 1980-06-23 | 1982-01-14 | Boehringer Mannheim Gmbh, 6800 Mannheim | Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
FR2568878B1 (fr) * | 1984-08-07 | 1986-11-21 | Cortial | Nouveaux derives de (phenylpiperazinylethylamine ethoxy)-4 phenol, leur methode de preparation et leur application therapeutique |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA967965A (en) * | 1968-12-24 | 1975-05-20 | Hoffmann-La Roche Limited | Aromatic ethers and process for the manufacture thereof |
FR2068051A5 (no) * | 1969-11-26 | 1971-08-20 | Robert Jean | |
CA1012540A (en) * | 1972-06-17 | 1977-06-21 | Sumitomo Chemical Company | 2-propanol derivatives and preparation thereof |
DE2235597A1 (de) * | 1972-07-20 | 1974-01-31 | Boehringer Mannheim Gmbh | 1-eckige klammer auf 3-(5,6,7,8tetrahydronaphth-1-yl-oxy) -propyl eckige klammer zu -piperazin-derivate und verfahren zu ihrer herstellung |
-
1977
- 1977-04-04 GB GB14100/77A patent/GB1583372A/en not_active Expired
-
1978
- 1978-03-31 FR FR7809675A patent/FR2395264A1/fr active Granted
- 1978-03-31 YU YU767/78A patent/YU40513B/xx unknown
- 1978-04-01 DE DE19782814168 patent/DE2814168A1/de active Granted
- 1978-04-01 HU HU78DE957A patent/HU179952B/hu not_active IP Right Cessation
- 1978-04-01 PL PL1978205745A patent/PL112249B1/pl unknown
- 1978-04-03 CA CA300,288A patent/CA1124718A/en not_active Expired
- 1978-04-03 ZA ZA00781889A patent/ZA781889B/xx unknown
- 1978-04-03 AU AU34703/78A patent/AU516315B2/en not_active Expired
- 1978-04-03 CH CH354378A patent/CH638795A5/de not_active IP Right Cessation
- 1978-04-03 FI FI781009A patent/FI69627C/fi not_active IP Right Cessation
- 1978-04-03 ES ES468486A patent/ES468486A1/es not_active Expired
- 1978-04-03 NL NL7803540A patent/NL7803540A/xx not_active Application Discontinuation
- 1978-04-03 SU SU782596099A patent/SU893133A3/ru active
- 1978-04-03 AT AT233078A patent/AT360997B/de not_active IP Right Cessation
- 1978-04-03 SE SE7803742A patent/SE435507B/sv not_active IP Right Cessation
- 1978-04-03 DK DK146678A patent/DK145225C/da not_active IP Right Cessation
- 1978-04-03 BE BE6046420A patent/BE865642A/xx not_active IP Right Cessation
- 1978-04-03 CS CS782141A patent/CS249503B2/cs unknown
- 1978-04-03 NO NO781159A patent/NO149209C/no unknown
- 1978-04-04 AR AR271686A patent/AR222149A1/es active
- 1978-04-04 JP JP53039626A patent/JPS6038383B2/ja not_active Expired
- 1978-04-04 MX MX786995U patent/MX6120E/es unknown
Also Published As
Publication number | Publication date |
---|---|
NO149209C (no) | 1984-03-07 |
HU179952B (en) | 1983-01-28 |
PL112249B1 (en) | 1980-10-31 |
ES468486A1 (es) | 1979-01-16 |
DK146678A (da) | 1978-10-05 |
SU893133A3 (ru) | 1981-12-23 |
YU40513B (en) | 1986-02-28 |
ATA233078A (de) | 1980-07-15 |
FR2395264B1 (no) | 1980-03-07 |
DK145225B (da) | 1982-10-11 |
FI781009A (fi) | 1978-10-05 |
FI69627B (fi) | 1985-11-29 |
FI69627C (fi) | 1986-03-10 |
NO149209B (no) | 1983-11-28 |
PL205745A1 (pl) | 1979-05-07 |
SE7803742L (sv) | 1978-10-05 |
DE2814168A1 (de) | 1978-10-05 |
ZA781889B (en) | 1979-03-28 |
NL7803540A (nl) | 1978-10-06 |
CA1124718A (en) | 1982-06-01 |
AU3470378A (en) | 1979-10-11 |
YU76778A (en) | 1982-10-31 |
BE865642A (fr) | 1978-10-03 |
MX6120E (es) | 1984-11-19 |
JPS53130682A (en) | 1978-11-14 |
NO781159L (no) | 1978-10-05 |
DK145225C (da) | 1983-04-11 |
AR222149A1 (es) | 1981-04-30 |
FR2395264A1 (fr) | 1979-01-19 |
AU516315B2 (en) | 1981-05-28 |
SE435507B (sv) | 1984-10-01 |
AT360997B (de) | 1981-02-10 |
GB1583372A (en) | 1981-01-28 |
CH638795A5 (en) | 1983-10-14 |
JPS6038383B2 (ja) | 1985-08-31 |
DE2814168C2 (no) | 1989-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR920005113B1 (ko) | 정신병치료제 1-플루오로페닐부틸-4-(2-피리미디닐)피페라진 유도체의 제조방법. | |
JP3880842B2 (ja) | 1−〔(4−クロロフェニル)フェニルメチル〕ピペラジンの鏡像体およびその製造法 | |
US5622951A (en) | Piperazine derivatives as 5-HT antagonists | |
US3974158A (en) | 2-(Substituted anilino)methylmorpholines | |
NO754179L (no) | ||
US4404384A (en) | O-[3-(4-Substituted-piperazin-1-yl)-2-hydroxypropyl]-hydroxylamines | |
US5852019A (en) | Pyrimidinylpyrazole derivatives | |
US3674799A (en) | (4'-(phenyl-3 6-dihydro-1-(2h)-pyridyl)-2-hydroxy propoxy-anilides and derivatives thereof | |
AU644295B2 (en) | 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their use in therapeutics | |
IE44276B1 (en) | Oxygenated n-aryl-diazacyclic compounds | |
US3752810A (en) | Substituted n aminoalkyl arylamino imidazolines-(2) | |
JPS62230767A (ja) | アセトアミド誘導体、その製造方法およびその医薬への応用 | |
CS249503B2 (en) | Method of new 1-(3-/3,4,5-trimethoxyphenoxy/-2-hydroxypropyl-4-aryl-piperazine derivatives production | |
EP0406739A2 (en) | Piperidine derivative, method for preparation thereof, and a pharmaceutical composition comprising the same | |
US4442102A (en) | 1,5-Diphenylpyrazolin-3-one compounds, process and intermediates for preparation thereof and pharmaceutical compositions containing same | |
JPS6047255B2 (ja) | 2−アミノ−5−スルフアモイル−安息香酸アミドの製法 | |
US3988456A (en) | 1,2-Diphenylethanolamine derivatives and their salts and the preparation thereof | |
JPS5988467A (ja) | フエノキシアミノプロパノ−ル誘導体 | |
JPH02134374A (ja) | 中枢神経系に対し作用する置換芳香族化合物 | |
CA1285945C (en) | N-¬¬¬1-(2)naphthylenemethyl or quinol-6-ylmethyl)-4- piperidinyl|amino|-carbonyl|-6-quinolinecarboxamide compounds | |
US4778793A (en) | Dihydroquinolinone derivatives, processes for their preparation, medicaments containing them and their use, and intermediate products for their preparation | |
US4029786A (en) | Morpholine derivatives for treating depression | |
CS214759B2 (en) | Method of making the piperidin derivatives of esters of 4,5-diacyl-3-hydroxy-pyrrol-2-carboxyl acid | |
US3691176A (en) | 1-(4-fluorophenoxypropyl)-4-anilino-piperidines | |
EP0084292B1 (en) | N,n-disubstituted alkenamides and phenylalkenamides, processes for their production and their use as pharmaceuticals |